EV/EBITDA
-1.79
-0.35-24.31%
3 min ago
Summary:
Renovaro Biosciences EV/EBITDA is currently -1.79, with a fall of -0.35 (-24.31%) during the most recent trading day. Over the past year, it has increased by +4.02 (+69.19%). RENB EV/EBITDA is now -258.00% below its all-time high of -0.50.RENB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -24.3% |
| 1 m1 month | -94.6% |
| 3 m3 months | -62.7% |
| 6 m6 months | +35.8% |
| ytdytd | +65.8% |
| 1 y1 year | +69.2% |
| 5 y5 years | +96.4% |
RENB EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.70 | -155.7% | -1.79 | at low |
| 3 m | 3 months | -0.61 | -193.4% | -1.79 | at low |
| 6 m | 6 months | -0.61 | -193.4% | -3.40 | +47.4% |
| 1 y | 1 year | -0.61 | -193.4% | -9.49 | +81.1% |
| 3 y | 3 years | -0.50 | -258.0% | -15.49 | +88.4% |
| 5 y | 5 years | -0.50 | -258.0% | -52.60 | +96.6% |
| alltime | all time | -0.50 | -258.0% | -54.58 | +96.7% |
Renovaro Biosciences EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -1.79(-65.8%) |
| 2023 | -5.24(+835.7%) |
| 2022 | -0.56(-94.4%) |
| Date | Value |
|---|---|
| 2021 | -9.96(-27.2%) |
| 2020 | -13.68(-66.0%) |
| 2019 | -40.19(+246.5%) |
| 2018 | -11.60 |
FAQ
- What is Renovaro Biosciences EV/EBITDA?
- What is the all time high EV/EBITDA for Renovaro Biosciences?
- What is RENB EV/EBITDA year-to-date change?
- What is Renovaro Biosciences EV/EBITDA year-on-year change?
What is Renovaro Biosciences EV/EBITDA?
The current EV/EBITDA of RENB is -1.79
What is the all time high EV/EBITDA for Renovaro Biosciences?
Renovaro Biosciences all-time high EV/EBITDA is -0.50
What is RENB EV/EBITDA year-to-date change?
Renovaro Biosciences EV/EBITDA has changed by +3.45 (+65.84%) since the beginning of the year
What is Renovaro Biosciences EV/EBITDA year-on-year change?
Over the past year, RENB EV/EBITDA has changed by +4.02 (+69.19%)